Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 3.87 USD 7.5% Market Closed
Market Cap: 219.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

DSGN Price Targets Summary
Design Therapeutics Inc

Wall Street analysts forecast DSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DSGN is 7.48 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

DSGN Lowest Forecast
Wall Street Target
5.05 USD
30% Upside
DSGN Average Forecast
Wall Street Target
7.48 USD
93% Upside
DSGN Highest Forecast
Wall Street Target
12.6 USD
226% Upside
Lowest
Price Target
5.05 USD
30% Upside
Average
Price Target
7.48 USD
93% Upside
Highest
Price Target
12.6 USD
226% Upside
Design Therapeutics Inc Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
54% Upside
CUV
Clinuvel Pharmaceuticals Ltd
151% Upside
6855
Ascentage Pharma Group International
12% Upside
A
ACLX
Arcellx Inc
81% Upside
PTGX
Protagonist Therapeutics Inc
54% Upside
CUV
Clinuvel Pharmaceuticals Ltd
151% Upside
6855
Ascentage Pharma Group International
12% Upside
A
ACLX
Arcellx Inc
81% Upside
ALNY
Alnylam Pharmaceuticals Inc
14% Upside
ANAB
AnaptysBio Inc
84% Upside
S
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
36% Downside
KALV
Kalvista Pharmaceuticals Inc
142% Upside

Revenue
Forecast

Revenue Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

See Also

Summary
DSGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
DSGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DSGN stock valuation using valuation multiples.
Wall Street Estimates
DSGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DSGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DSGN's stock price target?
Price Target
7.48 USD

According to Wall Street analysts, the average 1-year price target for DSGN is 7.48 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.